Found: 328
Select item for more details and to access through your institution.
Engineering a "muco‐trapping" ACE2‐immunoglobulin hybrid with picomolar affinity as an inhaled, pan‐variant immunotherapy for COVID‐19.
- Published in:
- Bioengineering & Translational Medicine, 2024, v. 9, n. 4, p. 1, doi. 10.1002/btm2.10650
- By:
- Publication type:
- Article
Human neutralizing antibodies target a conserved lateral patch on H7N9 hemagglutinin head.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-48758-4
- By:
- Publication type:
- Article
The Emergence of Candida auris is Not Associated with Changes in Antifungal Prescription at Hospitals.
- Published in:
- Infection & Drug Resistance, 2024, v. 17, p. 1419, doi. 10.2147/IDR.S451742
- By:
- Publication type:
- Article
Development and Evaluation of an In-House Real-Time RT-PCR Targeting nsp10 Gene for SARS-CoV-2 Detection.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 6, p. 3552, doi. 10.3390/ijms25063552
- By:
- Publication type:
- Article
Post-COVID-19 Pandemic Rebound of Macrolide-Resistant Mycoplasma pneumoniae Infection: A Descriptive Study.
- Published in:
- Antibiotics (2079-6382), 2024, v. 13, n. 3, p. 262, doi. 10.3390/antibiotics13030262
- By:
- Publication type:
- Article
Autoantibodies against angiotensin‐converting enzyme 2 (ACE2) after COVID‐19 infection or vaccination.
- Published in:
- Journal of Medical Virology, 2023, v. 95, n. 12, p. 1, doi. 10.1002/jmv.29313
- By:
- Publication type:
- Article
An interferon-integrated mucosal vaccine provides pan-sarbecovirus protection in small animal models.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-42349-5
- By:
- Publication type:
- Article
Prevalence and Characteristics of Invasive Staphylococcus argenteus among Patients with Bacteremia in Hong Kong.
- Published in:
- Microorganisms, 2023, v. 11, n. 10, p. 2435, doi. 10.3390/microorganisms11102435
- By:
- Publication type:
- Article
An RNA-Scaffold Protein Subunit Vaccine for Nasal Immunization.
- Published in:
- Vaccines, 2023, v. 11, n. 10, p. 1550, doi. 10.3390/vaccines11101550
- By:
- Publication type:
- Article
Broad-spectrum humanized monoclonal neutralizing antibody against SARS-CoV-2 variants, including the Omicron variant.
- Published in:
- Frontiers in Cellular & Infection Microbiology, 2023, p. 01, doi. 10.3389/fcimb.2023.1213806
- By:
- Publication type:
- Article
A Pilot Study of Short-Course Oral Vitamin A and Aerosolised Diffuser Olfactory Training for the Treatment of Smell Loss in Long COVID.
- Published in:
- Brain Sciences (2076-3425), 2023, v. 13, n. 7, p. 1014, doi. 10.3390/brainsci13071014
- By:
- Publication type:
- Article
Whipple's disease presenting as weight gain and constipation in a Chinese woman.
- Published in:
- BMC Infectious Diseases, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12879-023-08276-y
- By:
- Publication type:
- Article
Cutaneous Mycobacterium szulgai infection in a patient with Cushing's syndrome: a case report and literature review.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Genomic bacterial load associated with bacterial genotypes and clinical characteristics in patients with scrub typhus in Hainan Island, Southern China.
- Published in:
- PLoS Neglected Tropical Diseases, 2023, v. 16, n. 4, p. 1, doi. 10.1371/journal.pntd.0011243
- By:
- Publication type:
- Article
Positive‐strand RNA viruses—a Keystone Symposia report.
- Published in:
- Annals of the New York Academy of Sciences, 2023, v. 1521, n. 1, p. 46, doi. 10.1111/nyas.14957
- By:
- Publication type:
- Article
Intranasal Boosting with Spike Fc-RBD of Wild-Type SARS-CoV-2 Induces Neutralizing Antibodies against Omicron Subvariants and Reduces Viral Load in the Nasal Turbinate of Mice.
- Published in:
- Viruses (1999-4915), 2023, v. 15, n. 3, p. 687, doi. 10.3390/v15030687
- By:
- Publication type:
- Article
Analogous comparison unravels heightened antiviral defense and boosted viral infection upon immunosuppression in bat organoids.
- Published in:
- Signal Transduction & Targeted Therapy, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41392-022-01247-w
- By:
- Publication type:
- Article
Corrigendum: Co-stimulation with TLR7 agonist imiquimod and inactivated Influenza virus particles promotes mouse B cell activation, differentiation, and accelerated antigen specific antibody production .
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1053779
- By:
- Publication type:
- Article
Gastrointestinal Colonization of Carbapenem-Resistant Acinetobacter baumannii : What Is the Implication for Infection Control?
- Published in:
- Antibiotics (2079-6382), 2022, v. 11, n. 10, p. N.PAG, doi. 10.3390/antibiotics11101297
- By:
- Publication type:
- Article
Cross-variant protection against SARS-CoV-2 infection in hamsters immunized with monovalent and bivalent inactivated vaccines.
- Published in:
- International Journal of Biological Sciences, 2022, v. 18, n. 12, p. 4781, doi. 10.7150/ijbs.72109
- By:
- Publication type:
- Article
Mixed genotypes of Orientia tsutsugamushi in conserved genes and a single immune-dominant tsa56 genotype discovered from a patient with scrub typhus in Hainan Island, China: a case report.
- Published in:
- BMC Infectious Diseases, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12879-022-07682-y
- By:
- Publication type:
- Article
Reply to Yau et al.
- Published in:
- 2022
- By:
- Publication type:
- Letter to the Editor
Peptidic defective interfering gene nanoparticles against Omicron, Delta SARS-CoV-2 variants and influenza A virus in vivo.
- Published in:
- Signal Transduction & Targeted Therapy, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41392-022-01138-0
- By:
- Publication type:
- Article
Control of Healthcare-Associated Carbapenem-Resistant Acinetobacter baumannii by Enhancement of Infection Control Measures.
- Published in:
- Antibiotics (2079-6382), 2022, v. 11, n. 8, p. N.PAG, doi. 10.3390/antibiotics11081076
- By:
- Publication type:
- Article
Risk Factors for Slow Viral Decline in COVID-19 Patients during the 2022 Omicron Wave.
- Published in:
- Viruses (1999-4915), 2022, v. 14, n. 8, p. 1714, doi. 10.3390/v14081714
- By:
- Publication type:
- Article
Hepatitis E Virus Species C Infection in Humans, Hong Kong.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 2, p. 288, doi. 10.1093/cid/ciab919
- By:
- Publication type:
- Article
Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Omicron Subvariant BA.2 in a Single-Source Community Outbreak.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. e44, doi. 10.1093/cid/ciac203
- By:
- Publication type:
- Article
Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant by Sera From BNT162b2 or CoronaVac Vaccine Recipients.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. e822, doi. 10.1093/cid/ciab1041
- By:
- Publication type:
- Article
Coronavirus Disease 2019 Messenger RNA Vaccines Associated With Delayed Onset of Breakthrough Infections and Fewer Radiographic Abnormalities.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. e905, doi. 10.1093/cid/ciab1062
- By:
- Publication type:
- Article
Reply to Correa et al.
- Published in:
- 2022
- By:
- Publication type:
- Letter to the Editor
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection by Intranasal or Intratesticular Route Induces Testicular Damage.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. e974, doi. 10.1093/cid/ciac142
- By:
- Publication type:
- Article
A trifunctional peptide broadly inhibits SARS-CoV-2 Delta and Omicron variants in hamsters.
- Published in:
- Cell Discovery, 2022, v. 8, n. 1, p. N.PAG, doi. 10.1038/s41421-022-00428-9
- By:
- Publication type:
- Article
A trifunctional peptide broadly inhibits SARS-CoV-2 Delta and Omicron variants in hamsters.
- Published in:
- Cell Discovery, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41421-022-00428-9
- By:
- Publication type:
- Article
Contribution of low population immunity to the severe Omicron BA.2 outbreak in Hong Kong.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-31395-0
- By:
- Publication type:
- Article
A bipotential organoid model of respiratory epithelium recapitulates high infectivity of SARS-CoV-2 Omicron variant.
- Published in:
- Cell Discovery, 2022, v. 8, n. 1, p. N.PAG, doi. 10.1038/s41421-022-00422-1
- By:
- Publication type:
- Article
A bipotential organoid model of respiratory epithelium recapitulates high infectivity of SARS-CoV-2 Omicron variant.
- Published in:
- Cell Discovery, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41421-022-00422-1
- By:
- Publication type:
- Article
Decreased Antibiotic Consumption Coincided with Reduction in Bacteremia Caused by Bacterial Species with Respiratory Transmission Potential during the COVID-19 Pandemic.
- Published in:
- Antibiotics (2079-6382), 2022, v. 11, n. 6, p. 746, doi. 10.3390/antibiotics11060746
- By:
- Publication type:
- Article
Intravenous Injection of Coronavirus Disease 2019 (COVID-19) mRNA Vaccine Can Induce Acute Myopericarditis in Mouse Model.
- Published in:
- Clinical Infectious Diseases, 2022, v. 74, n. 11, p. 1933, doi. 10.1093/cid/ciab707
- By:
- Publication type:
- Article
SARS-CoV-2 infection induces inflammatory bone loss in golden Syrian hamsters.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-30195-w
- By:
- Publication type:
- Article
Author Correction: SARS-CoV-2 infection induces inflammatory bone loss in golden Syrian hamsters.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Pathogenicity of SARS‐CoV‐2 Omicron.
- Published in:
- Clinical & Translational Medicine, 2022, v. 12, n. 5, p. 1, doi. 10.1002/ctm2.880
- By:
- Publication type:
- Article
Impact of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variant-Associated Receptor Binding Domain (RBD) Mutations on the Susceptibility to Serum Antibodies Elicited by Coronavirus Disease 2019 (COVID-19) Infection or Vaccination.
- Published in:
- Clinical Infectious Diseases, 2022, v. 74, n. 9, p. 1623, doi. 10.1093/cid/ciab656
- By:
- Publication type:
- Article
False Coronavirus Disease 2019 Cases due to Contamination by Inactivated Virus Vaccine.
- Published in:
- Clinical Infectious Diseases, 2022, v. 74, n. 8, p. 1485, doi. 10.1093/cid/ciab684
- By:
- Publication type:
- Article
Computation of Antigenicity Predicts SARS-CoV-2 Vaccine Breakthrough Variants.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.861050
- By:
- Publication type:
- Article
A Palmitic Acid-Conjugated, Peptide-Based pan-CoV Fusion Inhibitor Potently Inhibits Infection of SARS-CoV-2 Omicron and Other Variants of Concern.
- Published in:
- Viruses (1999-4915), 2022, v. 14, n. 3, p. 549, doi. 10.3390/v14030549
- By:
- Publication type:
- Article
Antibody Response of Combination of BNT162b2 and CoronaVac Platforms of COVID-19 Vaccines against Omicron Variant.
- Published in:
- Vaccines, 2022, v. 10, n. 2, p. 160, doi. 10.3390/vaccines10020160
- By:
- Publication type:
- Article
SPINK6 inhibits human airway serine proteases and restricts influenza virus activation.
- Published in:
- EMBO Molecular Medicine, 2022, v. 14, n. 1, p. 1, doi. 10.15252/emmm.202114485
- By:
- Publication type:
- Article
Vaccine‐breakthrough infection by the SARS‐CoV‐2 omicron variant elicits broadly cross‐reactive immune responses.
- Published in:
- Clinical & Translational Medicine, 2022, v. 12, n. 1, p. 1, doi. 10.1002/ctm2.720
- By:
- Publication type:
- Article
Immunogenicity of a Heterologous Prime-Boost COVID-19 Vaccination with mRNA and Inactivated Virus Vaccines Compared with Homologous Vaccination Strategy against SARS-CoV-2 Variants.
- Published in:
- Vaccines, 2022, v. 10, n. 1, p. 72, doi. 10.3390/vaccines10010072
- By:
- Publication type:
- Article
Corrigendum to: Intravenous Injection of Coronavirus Disease 2019 (COVID-19) mRNA Vaccine Can Induce Acute Myopericarditis in Mouse Model.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice